Health

President’s advisers signal willingness to “work with religious groups.”

Agency recommends statutory language for imposing user fees on biosimilar drug manufacturers.

The FDA cautions patients to undergo only approved stem cell treatments.

Regulatory conference highlights need for defined governance of laboratory developed diagnostic testing.

Guidelines require more vegetables, less fat.

The USDA would inspect operations while decreasing its focus on expensive slaughter line inspections.

Affordable Care Act requires approval of insurance company rate hikes for individual and small group plans.

Statutory change will ease medical training and health care delivery by the Department of Defense.

Legal scholar argues for combating obesity by regulating advertising and providing economic incentives.

Federal government should fund research using stem cells from unfertilized eggs.

Inconsistent enforcement of the UK’s health and safety regulations unduly burdens businesses.

New report shows regulatory playing field tilting far to the right.